Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens
| Autor: | Blackwell, K.L. *, Pegram, M.D., Tan-Chiu, E., Schwartzberg, L.S., Arbushites, M.C., Maltzman, J.D., Forster, J.K., Rubin, S.D., Stein, S.H., Burstein, H.J. |
|---|---|
| Zdroj: | In Annals of Oncology June 2009 20(6):1026-1031 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|